NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Review aims to implement a more personalised and multidisciplinary approach in treatment of menopause...
The Congressional Caucus heard how a unique partnership has significantly increased both the quality and...
Michelle, a 46-year-old female, underwent biopsy of a lesion in her left sided chest musculature in...
In this issue, highlights from the 2023 Gathering Around Cancer as well as national and international...
More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that...
The European Society for Medical Oncology and the American Society of Clinical Oncology (ESMO and ASCO)...
Results from a number of highly anticipated phase 3 clinical trials across the range of gynaecological...
Interim results from the phase 2 ENZA-p study (NCT04419402) show that adding 177Lu-PSMA-617 to enzalutamide...
Positive results from the TROPION-Breast01 phase 3 trial showed that a specifically engineered TROP2...
Shared decision-making is more than being attentive to patients’ needs or concerns – it also represents...
A multidisciplinary surgical approach implemented at the Mater Hospital, Dublin, has improved outcomes...
Welcome to the latest edition of Update Oncology and Haematology. Despite the ongoing pressure on healthcare...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT